What are the needs for transplantation treatment in vitiligo, and how good is it?

Editorial

Mats J Olsson. Arch Dermatol. 2004 Oct.

. 2004 Oct;140(10):1273-4.

doi: 10.1001/archderm.140.10.1273.

No abstract available

Comment on

Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo.
van Geel N, Ongenae K, De Mil M, Haeghen YV, Vervaet C, Naeyaert JM. van Geel N, et al. Arch Dermatol. 2004 Oct;140(10):1203-8. doi: 10.1001/archderm.140.10.1203. Arch Dermatol. 2004. PMID: 15492182 Clinical Trial.
Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
Mulekar SV. Mulekar SV. Arch Dermatol. 2004 Oct;140(10):1211-5. doi: 10.1001/archderm.140.10.1211. Arch Dermatol. 2004. PMID: 15492183